Trial Details
UNKNOWNBasic Information
| Clinical ID | c3155 |
|---|---|
| Identifier | NCT02452151 |
| Trial Title | Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative|Crohn's Disease |
| Interventions | DRUG: Infliximab-Biosimilar|DRUG: Infliximab-Innovator |
Participant Information
| Sponsor | Onze Lieve Vrouwe Gasthuis |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2015-08 |
|---|---|
| Primary Completion Date | 2016-08 |
| Completion Date | 2016-09 |